Literature DB >> 2594613

The effect of etofibrate on cholesterol and bile acid metabolism in the hamster.

E De Fabiani1, M Crestani, B Malavasi, M Del Puppo, F Farina, C Armocida, S Bellentani, G Quack, E Bosisio.   

Abstract

Hamsters were given etofibrate at a dose of 300 mg/kg body wt, by gavage for 5 days, while being fed a chow diet. After treatment, serum cholesterol levels were 27% lower compared to those of the control animals. A similar trend was observed for triglyceride levels. Hepatic lipid levels were unchanged by the treatment. HMG-CoA reductase and acylCoA cholesterol acyltransferase were decreased while cholesterol 7 alpha-hydroxylase was not significantly modified by etofibrate. A choleretic effect and an increase of cholesterol excretion into hepatic bile was observed in treated animals. Nevertheless, composition and cholesterol saturation index of gallbladder bile were similar in control and treated animals. With respect to controls, hepatic bile of treated hamsters contained a lesser amount of cholic and deoxycholic acid and a greater amount of ursodeoxycholic acid.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2594613     DOI: 10.1016/1043-6618(89)90198-9

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  1 in total

1.  Biliary lipids, lithogenic index and biliary drug concentrations during etofibrate and bezafibrate treatment.

Authors:  R Raedsch; J Plachky; N Wolf; G Simonis
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1995 Apr-Jun       Impact factor: 2.441

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.